distigmine has been researched along with tamsulosin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Koike, H; Nagai, H; Tada, M; Umeda, M | 1 |
| Kida, J; Matsuya, H; Okada, H; Sekido, N; Wakamatsu, D | 1 |
| Kida, J; Mashimo, H; Matsuya, H; Okada, H; Otsuki, T; Sekido, N; Wakamatsu, D | 1 |
1 review(s) available for distigmine and tamsulosin
| Article | Year |
|---|---|
[A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
Topics: Aged; Cholinesterase Inhibitors; Cholinesterases; Humans; Male; Pyridinium Compounds; Sulfonamides; Tamsulosin; Urinary Bladder, Neurogenic | 2004 |
2 other study(ies) available for distigmine and tamsulosin
| Article | Year |
|---|---|
Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Constriction, Pathologic; Female; Pyridinium Compounds; Rats; Rats, Wistar; Silicon; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder, Neurogenic; Urinary Retention; Urination; Urodynamics | 2014 |
EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Male; Pyridinium Compounds; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Tamsulosin; Thiazoles; Urinary Bladder, Underactive; Urological Agents | 2020 |